Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association.

@article{Sisson2011RadiationSI,
  title={Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association.},
  author={James C. Sisson and Johnathan S. de Freitas and I. R. Mcdougall and Lawrence T. Dauer and James R. Hurley and James D Brierley and Charlotte H. Edinboro and David Rosenthal and Michael J Thomas and Jason A. Wexler and Ernest Frimpong Asamoah and Anca M. Avram and Mira Milas and Carol M Greenlee},
  journal={Thyroid : official journal of the American Thyroid Association},
  year={2011},
  volume={21 4},
  pages={
          335-46
        }
}
BACKGROUND Radiation safety is an essential component in the treatment of patients with thyroid diseases by ¹³¹I. The American Thyroid Association created a task force to develop recommendations that would inform medical professionals about attainment of radiation safety for patients, family members, and the public. The task force was constituted so as to obtain advice, experience, and methods from relevant medical specialties and disciplines. METHODS Reviews of Nuclear Regulatory Commission… Expand
Comments regarding Practice Recommendations of the American Thyroid Association for radiation safety in the treatment of thyroid disease with radioiodine.
The authors of the recently published ‘‘Radiation Safety in the Treatment of Patients with Thyroid Diseases by Radioiodine (I): Practice Recommendations of the American Thyroid Association’’ (1) areExpand
Measurement of Radiation Exposure to Caregivers of Patients with Thyroid Diseases Treated with Iodine-131: A Review
TLDR
Family members should limit close interactions with an individual for some duration following thyroid therapy with I-131, as well as caregivers of patients with thyroid diseases treated with radioiodine (I-131). Expand
First-day iodine kinetics is useful for individualizing radiation safety precautions for thyroid carcinoma patients
TLDR
It is possible to individualize radiation safety precautions by taking into account the iodine pharmacokinetics and living conditions of a patient by measuring the activity content within the body for the first 24 h after radioiodine administration. Expand
Thyroid cancer: radiation safety precautions in 131I therapy based on actual biokinetic measurements.
TLDR
Precaution times necessary to avoid close contact with family members and the general public were derived from these parameters and regulatory dose limits, and the actual mean effective (131)I half-life in the thyroid remnant tissue was greatly lower than that described in the ATA and NRC models. Expand
Radioactive iodine therapy
  • Stephanie L. Lee
  • Medicine
  • Current opinion in endocrinology, diabetes, and obesity
  • 2012
TLDR
Review of the management decisions and practice of RAI therapy will educate the endocrinologist of the literature supporting current RAI use in hyperthyroidism and new developments in limiting the radiation exposure to the patients with differentiated thyroid cancer. Expand
Radiation Dose Assessment to Family Members Taking Care of Non-Cancerous Thyroid Patients Treated with I-131 Therapy in Nuclear Medicine Department.
TLDR
It was showed that radiation doses received by caregivers of non-cancerous patients are higher than that of cancerous patients, nevertheless their received doses were within the international limits, thereby indicating good compliance by the caregivers to RSI. Expand
Radiation Safety Precautions in (131)I Therapy of Graves' Disease Based on Actual Biokinetic Measurements.
TLDR
The use of actual biokinetic measurements may remove the effect of variability errors associated with general default assumptions about the (131)I biokinetics in GD patients, and reinforces the need for patient-specific iodine biokinetically measurements for radiation safety precautions. Expand
High-Dose Radioiodine Outpatient Treatment: An Initial Experience in Thailand
TLDR
A safe 131I outpatient treatment in patients with thyroid carcinoma could be achieved by selective screening and providing instructions for patients and their caregivers, particularly for the safety of caregivers. Expand
Radiological Justification for and Optimization of Nuclear Medicine Practices in Korea
  • B. Kim
  • Medicine
  • Journal of Korean medical science
  • 2016
TLDR
The development of patient-radiation-dose monitoring software, and a national registry and management system of patients and radiopharmaceuticals must take into account the medical reality of Korea, in order to implement reasonable radiological justification and optimization. Expand
Selected Radiation Safety Aspects Including Transportation and Lodging After Outpatient 131I Therapy for Differentiated Thyroid Cancer.
TLDR
A survey of patients treated with 131I for differentiated thyroid cancer as an outpatient on selected aspects of radiation safety regarding their last outpatient 131I treatment found no discussion on the choice of an inpatient or outpatient treatment. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 57 REFERENCES
Current safety practices relating to I-131 administration for diseases of the thyroid: a survey of physicians and allied practitioners.
TLDR
A wide variety of safety recommendations are given to patients who receive I-131 treatment, and the diversity of responses suggests an opportunity for multispecialty collaboration in defining more uniform recommendations for patient safety instructions during and after I- 131 treatment. Expand
Comments regarding Practice Recommendations of the American Thyroid Association for radiation safety in the treatment of thyroid disease with radioiodine.
The authors of the recently published ‘‘Radiation Safety in the Treatment of Patients with Thyroid Diseases by Radioiodine (I): Practice Recommendations of the American Thyroid Association’’ (1) areExpand
Radioactive iodine therapy
  • Stephanie L. Lee
  • Medicine
  • Current opinion in endocrinology, diabetes, and obesity
  • 2012
TLDR
Review of the management decisions and practice of RAI therapy will educate the endocrinologist of the literature supporting current RAI use in hyperthyroidism and new developments in limiting the radiation exposure to the patients with differentiated thyroid cancer. Expand
Release of patients after therapy with unsealed radionuclides
TLDR
Young children and infants, as well as visitors not engaged in direct care or comforting, should be treated like other members of the public and be subject to the public dose limit, the present report recommends. Expand
Survey of radioiodine therapy safety practices highlights the need for user-friendly recommendations.
  • R. Kloos
  • Medicine
  • Thyroid : official journal of the American Thyroid Association
  • 2011
TLDR
The practice of keeping radiation exposure to others As Low As Reasonably Achievable (ALARA) is justified despite the lack of a case report of infantile hypothyroidism ascribed to radioiodine ingestion from breastfeeding. Expand
Radiation exposure from outpatient radioactive iodine (131I) therapy for thyroid carcinoma.
TLDR
In this study, 131I doses to household members of patients receiving outpatient 131I therapy were well below the limit (5.0 mSv) mandated by current NRC regulations. Expand
Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?
TLDR
The treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, can be safe when overseen by qualified professionals and with an adapted radiation-protection guideline. Expand
Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome
TLDR
It is concluded that a target dose of 250 Gy is essential to achieve hypothyroidism within 1 year after radioiodine therapy in Graves' disease patients with goitres up to 40 ml in volume. Expand
LICENSEE OVER-RELIANCE ON CONSERVATISMS IN NRC GUIDANCE REGARDING THE RELEASE OF PATIENTS TREATED WITH 131I
TLDR
It is maintained that professionals evaluating compliance with the NRC requirements for patient release, pursuant to 10 CFR 35.75, should use the procedures presented here and not rely automatically on the NUREG, which has been shown to be overly conservative. Expand
Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
TLDR
Indication of an influence of the residence time of radioiodine in the blood on the fractional uptake into thyroid remnant was found and a novel regimen is proposed in which therapeutic activities to be administered are determined from the individual specific blood dose. Expand
...
1
2
3
4
5
...